Sufentanil
Composition
This formulation contain Sufentanil as active agent
Indications
It is primarily indicated for the management of acute and chronic pain, particularly in the perioperative setting, and as an adjunct to general anesthesia
Side effects
respiratory depression, sedation, nausea, vomiting, constipation, and dizziness
Precautions
used with caution in patients with respiratory disorders, cardiovascular disease, or a history of substance abuse
Contraindications
Dosage and administration
directed by a healthcare professional
Countries
Worldwide
Available Forms
injections,Patches,Tablets
Manufacturing Services
Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai